Research Topics
| Ethel S GilbertSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohortE S Gilbert
Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20852, USA
Radiat Res 179:332-42. 2013..Large bioassay measurement errors alone are likely to have resulted in serious underestimation of risks, whereas other sources of uncertainty may have biased results in ways that are difficult to predict...
Health effects from falloutEthel S Gilbert
Division of Cancer Epidemiotogy and Genetics, National Cancer Institute, NIH, Rockville, MD 20852, USA
Health Phys 82:726-35. 2002..Very preliminary estimates of cancer risks from fallout doses received by the United States population are presented...
Ionising radiation and cancer risks: what have we learned from epidemiology?Ethel S Gilbert
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA
Int J Radiat Biol 85:467-82. 2009..Persons exposed early in life have especially high relative risks for many cancers, and radiation-related risk of solid cancers appears to persist throughout life...- Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an updateEthel S Gilbert
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7238, USA
Radiat Res 173:659-64. 2010..Nevertheless, the study adds support for an increased risk of thyroid cancer due to fallout, although the data are inadequate to quantify it... - External dose estimation for nuclear worker studiesE S Gilbert
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
Radiat Res 166:168-73. 2006..Based on these efforts, facility- and calendar year-specific adjustment factors have been developed, which will allow risks to be expressed as functions of organ doses with reasonable confidence... - Lung cancer after treatment for Hodgkin's disease: focus on radiation effectsE S Gilbert
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda Maryland 20852 7238, USA
Radiat Res 159:161-73. 2003.... - The impact of dosimetry uncertainties on dose-response analysesEthel S Gilbert
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Room 7050, Bethesda, MD 20892, USA
Health Phys 97:487-92. 2009.... - Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term riskAnil K Chaturvedi
Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
J Natl Cancer Inst 99:1634-43. 2007.... - Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patientsSara J Schonfeld
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-7238, USA
J Natl Cancer Inst 98:215-8. 2006..The EAR of AML declined statistically significantly after 1984 (7.0 to 4.2 and 16.4 to 9.9 in the < 35 and > or = 35 age groups, respectively), which may be associated with modifications in chemotherapy... - Risk of salivary gland cancer after childhood cancer: a report from the childhood cancer survivor studyHouda Boukheris
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Int J Radiat Oncol Biol Phys 85:776-83. 2013..To evaluate effects of radiation therapy, chemotherapy, cigarette smoking, and alcohol consumption on the risk of second primary salivary gland cancer (SGC) in the Childhood Cancer Survivor Study (CCSS)... - Second cancers after squamous cell carcinoma and adenocarcinoma of the cervixAnil K Chaturvedi
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
J Clin Oncol 27:967-73. 2009..We assessed whether these cofactor differences translate into differences in second cancer risk... - Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancerStefan Lonn
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 19:464-74. 2010..Adjuvant radiotherapy is common for uterine corpus cancer patients, yet the long-term carcinogenic effects of different types of radiotherapy have not been studied adequately... - Leukemia following breast cancer: an international population-based study of 376,825 womenRegan A Howard
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Executive Plaza South, Suite 7091, Bethesda, MD 20892, USA
Breast Cancer Res Treat 105:359-68. 2007.... - Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationOla Landgren
Division of Cancer Epidemiology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Blood 113:4992-5001. 2009..Our findings identify subgroups of patients who underwent allogeneic HCT at elevated risk of PTLDs for whom prospective monitoring of Epstein-Barr virus activation and early treatment intervention may be particularly beneficial... - Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008Lindsay M Morton
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD
Blood 121:2996-3004. 2013..tAML risks should be weighed against the benefits of chemotherapy, particularly for new agents and new indications for standard agents... - Second cancers among 40,576 testicular cancer patients: focus on long-term survivorsLois B Travis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
J Natl Cancer Inst 97:1354-65. 2005..Although second primary cancers are a leading cause of death among men with testicular cancer, few studies have quantified risks among long-term survivors... - Interactive RadioEpidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancersDavid C Kocher
SENES Oak Ridge, Inc, 102 Donner Drive, Oak Ridge, TN 37830, USA
Health Phys 95:119-47. 2008.... - Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphomaDavid C Hodgson
Princess Margaret Hospital, University Health Network, and the Department of Radiation Oncology, University of Toronto, Canada
J Clin Oncol 25:1489-97. 2007..However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis... - Some statistical implications of dose uncertainty in radiation dose-response analysesDaniel W Schafer
Department of Statistics, Oregon State University, Corvallis, Oregon, USA
Radiat Res 166:303-12. 2006.... - Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accidentElisabeth Cardis
International Agency for Research on Cancer, Lyon, France
Int J Cancer 119:1224-35. 2006.... - Lung, liver and bone cancer mortality in Mayak workersMikhail E Sokolnikov
Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Region, Russian Federation
Int J Cancer 123:905-11. 2008..These results will play an important role in plutonium risk assessment...